BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Staging
8 results:

  • 1. TNM staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma.
    Jimenez C; Ma J; Roman Gonzalez A; Varghese J; Zhang M; Perrier N; Habra MA; Graham P; Waguespack SG
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1132-1142. PubMed ID: 36433823
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A comprehensive validation of the novel 8th edition of American Joint Committee on cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms.
    Yang M; Zeng L; Yao WQ; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
    Medicine (Baltimore); 2020 Nov; 99(46):e22291. PubMed ID: 33181635
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pathological risk factors for metastatic disease at presentation in testicular seminomas with focus on the recent pT changes in AJCC TNM eighth edition.
    Scandura G; Wagner T; Beltran L; Alifrangis C; Shamash J; Berney DM
    Hum Pathol; 2019 Dec; 94():16-22. PubMed ID: 31666197
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Accuracy of Intraoperative Frozen Section Diagnosis of Borderline Ovarian Tumors by Hospital Type.
    Shah JS; Mackelvie M; Gershenson DM; Ramalingam P; Kott MM; Brown J; Gauthier P; Nugent E; Ramondetta LM; Frumovitz M
    J Minim Invasive Gynecol; 2019 Jan; 26(1):87-93. PubMed ID: 29680231
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer.
    van der Geest LGM; Lemmens VEPP; de Hingh IHJT; van Laarhoven CJHM; Bollen TL; Nio CY; van Eijck CHJ; Busch ORC; Besselink MG;
    Br J Surg; 2017 Oct; 104(11):1568-1577. PubMed ID: 28832964
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    Cancer Lett; 2015 Jun; 362(1):122-30. PubMed ID: 25819031
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT.
    Kitajima K; Murakami K; Yamasaki E; Kaji Y; Fukasawa I; Inaba N; Sugimura K
    Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1912-20. PubMed ID: 18682935
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.